CLARA LOUISE MAASS: A NURSE VOLUNTEER FOR YELLOW FEVER INOCULATIONS-1901TIGERTT HB.1983; MILITARY MEDICINE; ISSN 0026-4075; USA; DA. 1983; VOL. 148; NO 3; PP. 252-253; BIBL. 12 REF.Article

UNE POUSSEE EPIZOOTIQUE DE FIEVRE JAUNE SELVATIQUE AU SENEGAL ORIENTAL. ISOLEMENT DU VIRUS DE LOTS DE MOUSTIQUES ADULTES MALES ET FEMELLESCORNET M; ROBIN Y; HEME G et al.1979; MED. MAL. INFECT.; FRA; DA. 1979; VOL. 9; NO 2; PP. 63-66; BIBL. 12 REF.Article

THE DEVELOPMENT OF AN IMPROVED EXPERIMENTAL YELLOW FEVER VACCINETANNOCK GA; WARK MC; HAIR CG et al.1980; J. BIOL. STANDARDIZ.; GBR; DA. 1980; VOL. 8; NO 1; PP. 23-34; BIBL. 12 REF.Article

A YELLOW FEVER EPIZOOTIC IN ZIKA FOREST, UGANDA, DURING 1972. I. VIRUS ISOLATION AND SENTINEL MONKEYS.KIRYA BG; MURWAYA LG; SEMPALA SDK et al.1977; TRANS. SOC. TROP. MED. HYG.; G.B.; DA. 1977; VOL. 71; NO 3; PP. 254-260; BIBL. 12 REF.Article

EPIDEMIOLOGIE DE LA FIEVRE JAUNE EN AFRIQUE.CORDELLIER R; GERMAIN M; MOUCHET J et al.1976; MED. TROP.; FR.; DA. 1976; VOL. 36; NO 5; PP. 445-450; ABS. ANGL.; BIBL. 1 P.Article

A.W.H.O COLLABORATIVE STUDY OF IN VITRO AND IN VITRO METHODS FOR THE ASSAY OF YELLOW FEVER VACCINES = ETUDE EN COLLABORATION O.M.S. DES METHODES IN VITRO ET IN VIVO DE TITRAGE DES VACCINS CONTRE LA FIEVRE JAUNESEAGROATT V; MAGRATH DI.1983; JOURNAL OF BIOLOGICAL STANDARDIZATION; ISSN 0092-1157; USA; DA. 1983; VOL. 11; NO 1; PP. 47-54; BIBL. 6 REF.Article

Experimental therapies for yellow feverJULANDER, Justin G.Antiviral research. 2013, Vol 97, Num 2, pp 169-179, issn 0166-3542, 11 p.Article

Advanced Yellow Fever Virus Genome Detection in Point-of-Care Facilities and Reference LaboratoriesDOMINGO, Cristina; PATEL, Pranav; YILLAH, Jasmin et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 12, pp 4054-4060, issn 0095-1137, 7 p.Article

An RNA Pseudoknot Is Required for Production of Yellow Fever Virus Subgenomic RNA by the Host Nuclease XRN1SILVA, Patricia A. G. C; PEREIRA, Carina F; DALEBOUT, Tim J et al.Journal of virology. 2010, Vol 84, Num 21, pp 11395-11406, issn 0022-538X, 12 p.Article

Yellow Fever Virus Maintenance in Trinidad and Its Dispersal throughout the AmericasAUGUSTE, Albert J; LEMEY, Philippe; PYBUS, Oliver G et al.Journal of virology. 2010, Vol 84, Num 19, pp 9967-9977, issn 0022-538X, 11 p.Article

Functional requirements of the yellow fever virus capsid proteinPATKAR, Chinmay G; JONES, Christopher T; CHANG, Yu-Hsuan et al.Journal of virology. 2007, Vol 81, Num 12, pp 6471-6481, issn 0022-538X, 11 p.Article

Yellow fever virus NS3 protease : peptide-inhibition studiesLÖHR, Kristina; KNOX, John E; GANG WANG et al.Journal of general virology. 2007, Vol 88, pp 2223-2227, issn 0022-1317, 5 p., 8Article

Development of a membrane adsorber based capture step for the purification of yellow fever virusPATO, Tânia P; SOUZA, Marta Cristina O; SILVA, Andréa N. M. R et al.Vaccine. 2014, Vol 32, Num 24, pp 2789-2793, issn 0264-410X, 5 p.Conference Paper

The small nuclear ribonucleoprotein U1A interacts with NS5 from yellow fever virusBRONZONI, Roberta V. M; MADRID, Maria C. F. S; LUTZ, Carol S et al.Archives of virology. 2011, Vol 156, Num 6, pp 931-938, issn 0304-8608, 8 p.Article

Conservation of the pentanucleotide motif at the top of the yellow fever virus 17D 3' stem-loop structure is not required for replicationSILVA, Patricia A. G. C; MOLENKAMP, Richard; DALEBOUT, Tim J et al.Journal of general virology. 2007, Vol 88, pp 1738-1747, issn 0022-1317, 10 p., 6Article

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010BREUGELMANS, J. G; LEWIS, R. F; YACTAYO, S et al.Vaccine. 2013, Vol 31, Num 14, pp 1819-1829, issn 0264-410X, 11 p.Article

Production of pseudoinfectious yellow fever virus with a two-component genomeSHUSTOV, Alexandr V; MASON, Peter W; FROLOV, Ilya et al.Journal of virology. 2007, Vol 81, Num 21, pp 11737-11748, issn 0022-538X, 12 p.Article

Interaction between the yellow fever virus nonstructural protein NS3 and the host protein Alix contributes to the release of infectious particlesCARPP, Lindsay N; GALLER, Ricardo; BONALDO, Myrna C et al.Microbes and infection. 2011, Vol 13, Num 1, pp 85-95, issn 1286-4579, 11 p.Article

VACCINATION ANTIAMARILE ET GROSSESSEBOSCO MICHEL.1980; ; FRA; LYON: ASSOCIATION CORP. ETUDIANTS MED. LYON; DA. 1980; 56 P.; 30 CM; BIBL. 31 REF.; TH.: MED./LYON/1980/407Thesis

EIN BEITRAG ZUR GELBFIABERVIRUS-17D-INFEKTION IN HUEHNEREMBRYONEN. = UNE ETUDE DE L'INFECTION PAR LE VIRUS DE LA FIEVRE JAUNE 17 D D'EMBRYONS DE POULETTINNEFELD L; HAASE J; MUSETEANU C et al.1977; ZBL. BAKTERIOL. PARASITENKDE INFEKT.-KRANKH. HYG., 1, A; DTSCH.; DA. 1977; VOL. 237; NO 4; PP. 453-469; ABS. ANGL.; BIBL. 13 REF.Article

VACCINATION ANTIAMARILEMONNET R.1978; LYON MED.; FRA; DA. 1978; VOL. 240; NO 18; PP. 419-424; ABS. ENG; BIBL. 21 REF.Article

INFLUENCE OF VARIOUS TEMPERATURES IN RELATION TO TIME ON 17-D YELLOW FEVER VIRUS VACCINES.LUCASSE C; VISSER C.1978; J. BIOL. STANDARDIZ.; G.B.; DA. 1978; VOL. 6; NO 1; PP. 1-11; BIBL. 4 REF.Article

PLACE DE L'HOMME DANS LES CYCLES EPIDEMIOLOGIQUES DE LA FIEVRE JAUNE EN AFRIQUE DE L'OUEST.CORNET R; JAN C; COZ J et al.1977; MED. TROP.; FR.; DA. 1977; VOL. 37; NO 3; PP. 265-268; ABS. ANGL.; BIBL. 9 REF.Article

YELLOW FEVER IN THE GAMBIA, 1978-1979: EPIDEMIOLOGIC ASPECTS WITH OBSERVATIONS ON THE OCCURRENCE OF ORUNGO VIRUS INFECTIONSMONATH TP; CRAVEN RB; ADJUKIEWICZ A et al.1980; ANN. J. TROP. MED. HYG.; ISSN 0002-9637; USA; DA. 1980; VOL. 29; NO 5; PART. 1; PP. 912-928; BIBL. 24 REF.Article

The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe casesJOHANSSON, Michael A; VASCONCELOS, Pedro F. C; STAPLES, J. Erin et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014, Vol 108, Num 8, pp 482-487, issn 0035-9203, 6 p.Article